| Date | Title | Description | Source |
| 29.04.2024 | China's top Covid-19 vaccine scientist expelled from Parliam... | - | business-s... |
| 09.01.2023 | COVID-19 vaccines: From nasal drops to a redesign, what 2023... | Several vaccine companies say they are expecting breakthroughs as early as this year as they pursue ... | cbsnews.co... |
| 06.09.2022 | Covid-19 roundup: CanSino’s inhaled vaccine gets thumbs-u... | While the world has been focused on injectable booster shots to address the Omicron variant, o... | endpts.com... |
| 19.05.2022 | CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emerg... | TIANJIN, China, May 19, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 6... | en.prnasia... |
| 25.04.2022 | CanSinoBIO Rebrands to Reflect Commitment to Life Sciences R... | TIANJIN, China, April 25, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of &qu... | en.prnasia... |
| 04.04.2022 | CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clin... | TIANJIN, April 4, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the C... | en.prnasia... |
| 22.03.2022 | CanSinoBIO's Convidecia™ Approved as Heterologous Booster in... | TIANJIN, China, March 22, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE:... | en.prnasia... |
| 14.03.2022 | Latest Study Shows Advantages of CanSinoBIO's Convidecia™ as... | TIANJIN, China, March 14, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE:... | en.prnasia... |
| 21.02.2022 | CanSinoBIO's Convidecia™ Approved as Heterologous Booster in... | TIANJIN, China, Feb. 21, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: ... | en.prnasia... |
| 17.01.2022 | Covid: la tecnologia dell’irlandese Aerogen per il 1° vaccin... | Un vaccino anti Covid via aerosol? Non è fantascienza, ma realtà grazie all’irlandese Aerogen, leade... | startup-ne... |
| 12.01.2022 | CanSino Biologics : Could CanSino's inhaled coronavirus vacc... | Could CanSino's inhaled coronavirus vaccine booster be a quick, needle-free option?
2022-01
Study fi... | marketscre... |
| 11.01.2022 | Latest Study Shows Encouraging Results of CanSinoBIO's Inhal... | TIANJIN, China, Jan. 11, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: ... | en.prnasia... |
| 09.01.2022 | CanSinoBIO Announces Approval for its MCV4 Product Menhycia™... | TIANJIN, China, Jan. 9, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 6... | en.prnasia... |
| 24.06.2021 | CanSino Biologics : CanSinoBIO Announces Approval for Its Gr... | CanSinoBIO Announces Approval for Its Group A and Group C Meningococcal Conjugate Vaccine in China
2... | marketscre... |
| 24.05.2021 | CanSinoBIO Receives European GMP Certification for its COVID... | A major step for introducing Convidecia™ to more countries and people in need for protection
Vaccine... | en.prnasia... |
| 22.05.2021 | CANSINO BIOLOGICS INC.
CanSino Biologics : CanSinoBIO Recei... | CanSinoBIO Receives EU GMP Certificate
2021-05
Tianjin, May 21, 2021
CanSino Biologics Inc. ('CanSin... | marketscre... |
| 26.03.2021 | CANSINO BIOLOGICS INC.
CanSino Biologics : ANNUAL RESULTS A... | Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no respons... | marketscre... |
| 26.03.2021 | CanSino Biologics : ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR... | Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no respons... | marketscre... |
| 16.04.2020 | Covid-19 vaccine tracker updated to include GSK/Sanofi ... | By Jeff Craven
Currently, there are no FDA-approved therapies or vaccines for SARS-CoV-2, the ... | endpts.com... |
| 09.04.2020 | Covid-19 Tracker updates vaccine candidates | By Jeff Craven
On March 11, the World Health Organization classified the Covid-19 outbreak as... | endpts.com... |
| 19.03.2020 | An updated guide to the coronavirus drugs and vaccines in de... | In the months since the novel coronavirus rose from a regional crisis to a global threat, drug maker... | statnews.c... |
| 29.01.2016 | China’s Qiming Venture Partners closing $650M fund, reaches ... | The company says it has invested more than $600 million in the healthcare sector in the past seven y... | medcitynew... |
| - | China’s Qiming Venture Partners closing $650M fund, reaches ... | China-based investment firm Qiming Venture Partners has been raising a $650 million fund – its fifth... | medcitynew... |
